[HTML][HTML] Targeting the opioid remifentanil: protective effects and molecular mechanisms against organ ischemia-reperfusion injury
S Yi, H Cao, W Zheng, Y Wang, P Li, S Wang… - Biomedicine & …, 2023 - Elsevier
Opioids are widely used in clinical practice by activating opioid receptors (OPRs), but their
clinical application is limited by a series of side effects. Researchers have been making …
clinical application is limited by a series of side effects. Researchers have been making …
Targeting the opioid remifentanil: Protective effects and molecular mechanisms against organ ischemia-reperfusion injury.
S Yi, H Cao, W Zheng, Y Wang, P Li… - Biomedicine & …, 2023 - europepmc.org
Opioids are widely used in clinical practice by activating opioid receptors (OPRs), but their
clinical application is limited by a series of side effects. Researchers have been making …
clinical application is limited by a series of side effects. Researchers have been making …
Targeting the opioid remifentanil: Protective effects and molecular mechanisms against organ ischemia-reperfusion injury
S Yi, H Cao, W Zheng, Y Wang, P Li… - Biomedicine & … - pubmed.ncbi.nlm.nih.gov
Opioids are widely used in clinical practice by activating opioid receptors (OPRs), but their
clinical application is limited by a series of side effects. Researchers have been making …
clinical application is limited by a series of side effects. Researchers have been making …